ORIGINAL RESEARCH
Accepted on 25 Mar 2025
CXCR5 engineered human and murine Tregs for targeted suppression in secondary and tertiary lymphoid organs
doi 10.3389/fimmu.2025.1513009
- 446 views
- Frontiers in Immunology
- Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders
- Research Topics
- Repurposing Cancer Immunotherapies for Use in Autoimmunity and Transplantation
Repurposing Cancer Immunotherapies for Use in Autoimmunity and Transplantation
15k
Total downloads
49k
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Articles
BRIEF RESEARCH REPORT
Published on 18 Dec 2023
An orally available cancer drug AZD6738 prevents type 1 diabetes
doi 10.3389/fimmu.2023.1290058
- 1,533 views
- 1 citation
ORIGINAL RESEARCH
Published on 30 May 2023
Modeling cell-mediated immunity in human type 1 diabetes by engineering autoreactive CD8+ T cells
doi 10.3389/fimmu.2023.1142648
- 4,607 views
- 7 citations
ORIGINAL RESEARCH
Published on 10 May 2023
Dual inhibition of phosphoinositide 3-kinases delta and gamma reduces chronic B cell activation and autoantibody production in a mouse model of lupus
doi 10.3389/fimmu.2023.1115244
- 1,941 views
- 2 citations
REVIEW
Published on 19 Apr 2023
Opportunities for Treg cell therapy for the treatment of human disease
doi 10.3389/fimmu.2023.1166135
- 17,611 views
- 63 citations
REVIEW
Published on 14 Dec 2022
The emerging role of regulatory cell-based therapy in autoimmune disease
doi 10.3389/fimmu.2022.1075813
- 12,225 views
- 62 citations
MINI REVIEW
Published on 16 Nov 2022
The dichotomous outcomes of TNFα signaling in CD4+ T cells
doi 10.3389/fimmu.2022.1042622
- 7,589 views
- 3 citations
Published in
Frontiers in Immunology
Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
You will be redirected to our submission process.